Citation Impact
Citing Papers
New approaches and procedures for cancer treatment: Current perspectives
2021 Standout
Functional Genomic Analysis Identified Epidermal Growth Factor Receptor Activation as the Most Common Genetic Event in Oral Squamous Cell Carcinoma
2009
Molecular mechanisms mediating metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Targeting HER proteins in cancer therapy and the role of the non-target HER3
2007
Hallmarks of Cancer: The Next Generation
2011 Standout
Targeted glycan degradation potentiates the anticancer immune response in vivo
2020 StandoutNobel
The role of HER2 in cancer therapy and targeted drug delivery
2010
Histopathological and molecular heterogeneity among individuals with dementia associated with Presenilin mutations
2008
Gastric cancer
2016 Standout
Herceptin
2007
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
2020 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
Systems Biology of Growth Factor‐Induced Receptor Endocytosis
2008
Top 10 Challenges in Cancer Immunotherapy
2020
Combining Immune Checkpoint Inhibitors With Conventional Cancer Therapy
2018
Derailed endocytosis: an emerging feature of cancer
2008
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
2007 Standout
Cell Signaling by Receptor Tyrosine Kinases
2010 Standout
Presenilin 1 Mutants Impair the Self-Renewal and Differentiation of Adult Murine Subventricular Zone-Neuronal Progenitors via Cell-Autonomous Mechanisms Involving Notch Signaling
2010
The EGF receptor family: spearheading a merger of signaling and therapeutics
2007
Nuclear Translocation of Cell‐Surface Receptors: Lessons from Fibroblast Growth Factor
2005
Extracellular Matrix Degradation and Remodeling in Development and Disease
2011 Standout
The molecular biology of head and neck cancer
2010 Standout
EGF–ERBB signalling: towards the systems level
2006 Standout
BH3-only proteins in apoptosis and beyond: an overview
2008
Molecular mechanisms of cisplatin resistance
2011 Standout
Nuclear trafficking of secreted factors and cell-surface receptors: new pathways to regulate cell proliferation and differentiation, and involvement in cancers
2006
Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival
2006
Fibroblast growth factor signalling: from development to cancer
2010 Standout
Pyroptosis: mechanisms and diseases
2021 Standout
Targeting apoptosis in cancer therapy
2020 Standout
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Remodelling the extracellular matrix in development and disease
2014 Standout
Neuregulin 1 in neural development, synaptic plasticity and schizophrenia
2008
Adult Neurogenesis in the Mammalian Brain: Significant Answers and Significant Questions
2011 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
STATs in cancer inflammation and immunity: a leading role for STAT3
2009 Standout
Anti-Aβ Drug Screening Platform Using Human iPS Cell-Derived Neurons for the Treatment of Alzheimer's Disease
2011 StandoutNobel
Classic Selective Sweeps Revealed by Massive Sequencing in Cattle
2014 Standout
Hidradenitis suppurativa
2020 Standout
The Amyloid State of Proteins in Human Diseases
2012 Standout
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
2013 Standout
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
Cancer prevention by tea: animal studies, molecular mechanisms and human relevance
2009 Standout
The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism
2009 Standout
HER2 Transmembrane Domain (TMD) Mutations (V659/G660) That Stabilize Homo- and Heterodimerization Are Rare Oncogenic Drivers in Lung Adenocarcinoma That Respond to Afatinib
2016
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Signal Transducer and Activator of Transcription‐3, Inflammation, and Cancer
2009 Standout
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Caspases and Kinases in a Death Grip
2009
Presenilin diversifies its portfolio
2007
The Fibroblast Growth Factor signaling pathway
2015 Standout
The Many Substrates of Presenilin/γ-Secretase
2011
Apoptosis: A Target for Anticancer Therapy
2018 Standout
The ADAMs: signalling scissors in the tumour microenvironment
2008
Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway
2005
Prognostic Implications of Altered Human Epidermal Growth Factor Receptors (HERs) in Gastric Carcinomas: HER2 and HER3 Are Predictors of Poor Outcome
2011
The epithelial–mesenchymal transition: new insights in signaling, development, and disease
2006 Standout
Physiology of Microglia
2011 Standout
Hyper-Progressive Disease: The Potential Role and Consequences of T-Regulatory Cells Foiling Anti-PD-1 Cancer Immunotherapy
2020 StandoutNobel
Caspase‐8: regulating life and death
2017 Standout
Works of Gregory A. Vidal being referenced
The ERBB4/HER4 Intracellular Domain 4ICD Is a BH3-Only Protein Promoting Apoptosis of Breast Cancer Cells
2006
Presenilin-dependent γ-Secretase Processing Regulates Multiple ERBB4/HER4 Activities
2005
A constitutively active ERBB4/HER4 allele with enhanced transcriptional coactivation and cell-killing activities
2006
The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone
2004
MORPHEUS: A phase Ib/II umbrella study platform evaluating the safety and efficacy of multiple cancer immunotherapy (CIT)-based combinations in different tumour types
2018
TOPACIO/Keynote-162 (NCT02657889): A phase 1/2 study of niraparib + pembrolizumab in patients (pts) with advanced triple-negative breast cancer or recurrent ovarian cancer (ROC)—Results from ROC cohort.
2018